Notice of Meeting of the Advisory Committee on Organ Transplantation, 55494-55495 [06-8024]

Download as PDF 55494 Federal Register / Vol. 71, No. 184 / Friday, September 22, 2006 / Notices Send comments to Susan G. Queen, Ph.D., HRSA Reports Clearance Officer, Room 10–33, Parklawn Building, 5600 Fishers Lane, Rockville, MD 20857. Written comments should be received within 60 days of this notice. Dated: September 15, 2006. Cheryl R. Dammons, Director, Division of Policy Review and Coordination. [FR Doc. 06–8020 Filed 9–21–06; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: September 15, 2006. Cheryl R. Dammons, Director, Division of Policy Review and Coordination. [FR Doc. 06–8018 Filed 9–21–06; 8:45 am] Health Resources and Services Administration Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children; Notice of Meeting BILLING CODE 4165–15–P sroberts on PROD1PC70 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children (ACHDGDNC). Dates and Times: November 2, 2006, 9 a.m. to 5 p.m. November 3, 2006, 8:30 a.m. to 3 p.m. Place: Hilton Washington Hotel, Georgetown Room, 1919 Connecticut Avenue, NW., Washington, DC 20009. Status: The meeting will be open to the public with attendance limited to space availability. Purpose: The Committee was established specifically to advise and guide the Secretary regarding the most appropriate application of universal newborn screening tests, technologies, policies, guidelines and programs for effectively reducing morbidity and mortality in newborns and children having or at risk for heritable disorders. The Committee also provides advice and recommendations concerning the grants and projects authorized under the Heritable Disorders Program and technical information to develop policies and priorities for this program. The Heritable Disorders Program was established to enhance the ability of State and local health agencies to provide for newborn and child screening, counseling and health care services for newborns and children having or at risk for heritable disorders. Agenda: The meeting will include a report on the nomination process for newborn screening candidate conditions, as well as the continued work and reports by the Committee’s subcommittees on laboratory standards and procedures, follow-up and treatment, and education and training. Proposed agenda items are subject to change. Time will be provided each day for public comment. Individuals who wish to provide public comment or who plan to attend the VerDate Aug<31>2005 20:37 Sep 21, 2006 Jkt 208001 meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the ACHDGDNC Executive Secretary, Michele A. Lloyd-Puryear, M.D., Ph.D. (contact information provided below). For Further Information Contact: Anyone interested in obtaining a roster of members or other relevant information should write or contact Michele A. Lloyd-Puryear, M.D., Ph.D., Maternal and Child Health Bureau, Health Resources and Services Administration, Room 18A–19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, Telephone (301) 443–1080. Information on the Advisory Committee is available at https://mchb.hrsa.gov/programs/ genetics/committee. DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Notice of Meeting of the Advisory Committee on Organ Transplantation Health Resources and Services Administration, HHS. SUMMARY: Pursuant to Public Law 92– 463, the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the eleventh meeting of the Advisory Committee on Organ Transplantation (ACOT), Department of Health and Human Services (HHS). The meeting will be held from approximately 9 a.m. to 5:30 p.m. on November 2, 2006, and from 9 a.m. to 3 p.m. on November 3, 2006, at the Bethesda DoubleTree Hotel, 8120 Wisconsin Avenue, Bethesda, MD 20814. The meeting will be open to the public; however, seating is limited and pre-registration is encouraged (see below). SUPPLEMENTARY INFORMATION: Under the authority of 42 U.S.C. 217a, section 222 of the Public Health Service Act, as amended, and 42 CFR 121.12 (2000), ACOT was established to assist the Secretary in enhancing organ donation, ensuring that the system of organ transplantation is grounded in the best available medical science, and assuring the public that the system is as effective and equitable as possible, and, thereby, increasing public confidence in the integrity and effectiveness of the transplantation system. ACOT is composed of up to 25 members, including the Chair. Members are AGENCY: PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 serving as Special Government Employees and have diverse backgrounds in fields such as organ donation, health care public policy, transplantation medicine and surgery, critical care medicine and other medical specialties involved in the identification and referral of donors, non-physician transplant professions, nursing, epidemiology, immunology, law and bioethics, behavioral sciences, economics and statistics, as well as representatives of transplant candidates, transplant recipients, organ donors, and family members. ACOT will hear presentations on the revised Uniform Anatomical Gift Act; the United Network for Organ Sharing Department of Evaluation and Quality; the Hollywood Health and Society Project; new developments in immunosuppression; and payment for organs. The draft meeting agenda will be available on October 16 on the Department’s donation Web site at https://www.organdonor.gov/acot.html. A registration form will be available on October 2 on the Department’s donation Web site at https:// www.organdonor.gov/acot.html. The completed registration form should be submitted by facsimile to Professional and Scientific Associates (PSA), the logistical support contractor for the meeting, at fax number (703) 234–1701. Individuals without access to the Internet who wish to register may call Sowjanya Kotakonda with PSA at (703) 234–1737. Registration can also be completed electronically at https:// www.psava.com/dot/acot2006/. Individuals who plan to attend the meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the ACOT Executive Secretary, Remy Aronoff, in advance of the meeting. Mr. Aronoff may be reached by telephone at 301–443–3264, e-mail: Remy.Aronoff@hrsa.hhs.gov or in writing at the address provided below. Management and support services for ACOT functions are provided by the Division of Transplantation, Healthcare Systems Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Parklawn Building, Room 12C–06, Rockville, Maryland 20857; telephone number 301–443–7577. After the presentations and ACOT discussions, members of the public will have an opportunity to provide comments. Because of the Committee’s full agenda and the timeframe in which to cover the agenda topics, public comment will be limited. All public E:\FR\FM\22SEN1.SGM 22SEN1 55495 Federal Register / Vol. 71, No. 184 / Friday, September 22, 2006 / Notices comments will be included in the record of the ACOT meeting. Dated: September 12, 2006. Elizabeth M. Duke, Administrator. [FR Doc. 06–8024 Filed 9–21–06; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Request for Public Comment: 30-day Proposed Information Collection: Indian Health Service Contract Health Service Report Indian Health Service, HHS. The Indian Health Service (IHS), as part of its continuing effort to reduce paperwork and respondent burden, conducts a pre-clearance consultation program to provide the general public and Federal agencies with an opportunity to comment on proposed and/or continuing collections of information in accordance with the Paperwork Reduction Act of 1995 (44 U.S.C. 3506(c)(2)(A)). This program helps to ensure that requested data can be provided in the desired format, reporting burden (time and financial resources) is minimized, collection instruments are clearly understood, and the impact of collection requirements on respondents can be properly assessed. As required by section 3507(a)(1)(D) of the Act, the proposed information collection has been submitted to the AGENCY: SUMMARY: Office of Management and Budget (OMB) for review and approval. The IHS received no comments in response to the 60-day Federal Register notice (71 FR 39686) published on July 13, 2006. The purpose of this notice is to allow an additional 30 days for public comment to be submitted directly to OMB. Proposed Collection: Title: 0917– 0002, ‘‘Indian Health Service Contract Health Service Report.’’ Type of Information Collection Request: Extension of a currently approved information collection, 0917–0002, ‘‘Indian Health Service Contract Health Service Report.’’ Form Number: IHS 843–1A. Need and Use of Information Collection: The purpose for the collection is to authorize contract health care providers to provide health care services to eligible IHS patients. The IHS form 843–1A ‘‘Order for Health Services’’ was developed specifically for this collection of information. Other than revising the title ‘‘PurchaseDelivery Order for Health Services’’ to read ‘‘Order for Health Services’’, acquisition terms on the front of the form, the contract clauses contained on the back of copy 3 of the form, the form has not been revised and there is no change in the substance or in the use of the form. A copy of the form is at Attachment 2. The majority of the information contained in this form is completed by IHS staff from existing IHS automated patient and vendor data files. Contract health care providers complete and sign the streamlined form and submit it, Est. No. of respondents Data collection instrument Responses per respondent along with a completed standard Centers for Medicare & Medicaid Services (CMS) health claim form (CMS 1450 (UB 92) and CMS 1500), to the IHS for verification and payment. The CMS forms are used and accepted nationwide by the health care industry and IHS is an approved user. The information collected is needed to administer and manage the contract health care services provided to eligible American Indian and Alaska Native patients. The form is used to: Authorize contract health care services for eligible patients; certify that the health care services requested and authorized have been performed by the contract provider(s); process payments for health care services performed by such providers; obtain program data; and, serve as a legal document for health and medical care authorized by the IHS and rendered by health care providers under contract with the IHS. The information collected is also used for: Planning for further care of the patient; for keeping an accurate record of the patient’s health status and health services received and recommended; for planning future health care programs; for communicating among members of the health care team; for evaluating the health care rendered; for research and continuing education; and, for the provision of program health statistics. Affected Public: Individuals and households. Type of Respondents: Individuals. The table below provides the estimated burden hours for this information collection: Annual number of responses Burden per response Total annual burden hrs. IHS–843–1A ......................................................................... IDS* ...................................................................................... 7,399 13,717 42 1 272,506 13,717 0.05 0.05 13,625.3 685.8 Total .............................................................................. 21,116 ........................ ........................ ........................ 14,311.1 sroberts on PROD1PC70 with NOTICES *Inpatient Discharge Summary (IDS) There are no capital costs, operating costs and/or maintenance costs to respondents. Request for Comments: Your written comments and/or suggestions are invited on one or more of the following points: (a) Whether the information collection activity is necessary to carry out an agency function; (b) whether the agency processes the information collected in a useful and timely fashion; (c) the accuracy of public burden estimate (the estimated amount of time needed for individual respondents to provide the requested information); (d) whether the methodology and VerDate Aug<31>2005 20:37 Sep 21, 2006 Jkt 208001 assumptions used to determine the estimate are logical; (e) ways to enhance the quality, utility, and clarity of the information being collected; and (f) ways to minimize the public burden through the use of automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Direct Comments to OMB: Send your written comments and suggestions regarding the proposed information collection contained in this notice, especially regarding the estimated public burden and associated response time, to: Office of Management and PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 Budget, Office of Regulatory Affairs, New Executive Office Building, Room 10235, Washington, DC 20503, Attention: Allison Eydt, Desk Office for IHS. FOR FURTHER INFORMATION CONTACT: Send requests for more information on the proposed collection or to obtain a copy of the data collection instrument(s) and instructions to Mrs. Christina Rouleau, IHS Reports Clearance Officer, 801 Thompson Avenue, TMP, Suite 450, Rockville, MD 20852, call non-toll free (301) 443–5938, send via facsimile to (301) 443–2316, or send your e-mail E:\FR\FM\22SEN1.SGM 22SEN1

Agencies

[Federal Register Volume 71, Number 184 (Friday, September 22, 2006)]
[Notices]
[Pages 55494-55495]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-8024]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Notice of Meeting of the Advisory Committee on Organ 
Transplantation

AGENCY: Health Resources and Services Administration, HHS.

SUMMARY: Pursuant to Public Law 92-463, the Federal Advisory Committee 
Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the 
eleventh meeting of the Advisory Committee on Organ Transplantation 
(ACOT), Department of Health and Human Services (HHS). The meeting will 
be held from approximately 9 a.m. to 5:30 p.m. on November 2, 2006, and 
from 9 a.m. to 3 p.m. on November 3, 2006, at the Bethesda DoubleTree 
Hotel, 8120 Wisconsin Avenue, Bethesda, MD 20814. The meeting will be 
open to the public; however, seating is limited and pre-registration is 
encouraged (see below).

SUPPLEMENTARY INFORMATION: Under the authority of 42 U.S.C. 217a, 
section 222 of the Public Health Service Act, as amended, and 42 CFR 
121.12 (2000), ACOT was established to assist the Secretary in 
enhancing organ donation, ensuring that the system of organ 
transplantation is grounded in the best available medical science, and 
assuring the public that the system is as effective and equitable as 
possible, and, thereby, increasing public confidence in the integrity 
and effectiveness of the transplantation system. ACOT is composed of up 
to 25 members, including the Chair. Members are serving as Special 
Government Employees and have diverse backgrounds in fields such as 
organ donation, health care public policy, transplantation medicine and 
surgery, critical care medicine and other medical specialties involved 
in the identification and referral of donors, non-physician transplant 
professions, nursing, epidemiology, immunology, law and bioethics, 
behavioral sciences, economics and statistics, as well as 
representatives of transplant candidates, transplant recipients, organ 
donors, and family members.
    ACOT will hear presentations on the revised Uniform Anatomical Gift 
Act; the United Network for Organ Sharing Department of Evaluation and 
Quality; the Hollywood Health and Society Project; new developments in 
immunosuppression; and payment for organs.
    The draft meeting agenda will be available on October 16 on the 
Department's donation Web site at https://www.organdonor.gov/acot.html.
    A registration form will be available on October 2 on the 
Department's donation Web site at https://www.organdonor.gov/acot.html. 
The completed registration form should be submitted by facsimile to 
Professional and Scientific Associates (PSA), the logistical support 
contractor for the meeting, at fax number (703) 234-1701. Individuals 
without access to the Internet who wish to register may call Sowjanya 
Kotakonda with PSA at (703) 234-1737. Registration can also be 
completed electronically at https://www.psava.com/dot/acot2006/. 
Individuals who plan to attend the meeting and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the ACOT Executive Secretary, Remy 
Aronoff, in advance of the meeting. Mr. Aronoff may be reached by 
telephone at 301-443-3264, e-mail: Remy.Aronoff@hrsa.hhs.gov or in 
writing at the address provided below. Management and support services 
for ACOT functions are provided by the Division of Transplantation, 
Healthcare Systems Bureau, Health Resources and Services 
Administration, 5600 Fishers Lane, Parklawn Building, Room 12C-06, 
Rockville, Maryland 20857; telephone number 301-443-7577.
    After the presentations and ACOT discussions, members of the public 
will have an opportunity to provide comments. Because of the 
Committee's full agenda and the timeframe in which to cover the agenda 
topics, public comment will be limited. All public

[[Page 55495]]

comments will be included in the record of the ACOT meeting.

    Dated: September 12, 2006.
Elizabeth M. Duke,
Administrator.
[FR Doc. 06-8024 Filed 9-21-06; 8:45 am]
BILLING CODE 4165-15-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.